Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Richard L. Horner. (2023) Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies. Expert Opinion on Therapeutic Targets 27:7, pages 609-626.
Read now
Read now
Kaoru Kobayshi, Yoshikazu Abe, Asuka Kawai, Takao Furihata, Hiroshi Harada, Takuro Endo & Hiroo Takeda. (2019) Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro. Xenobiotica 49:12, pages 1434-1446.
Read now
Read now
Kaoru Kobayashi, Yoshikazu Abe, Hiroshi Harada, Emiko Oota, Takuro Endo & Hiroo Takeda. (2019) Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue. Xenobiotica 49:1, pages 106-119.
Read now
Read now
Tatsunori Takahashi, Sakai Noriaki, Mari Matsumura, Chenyu Li, Kayo Takahashi & Seiji Nishino. (2018) Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 6:10, pages 597-610.
Read now
Read now
Vivien C Abad & Christian Guilleminault. (2017) New developments in the management of narcolepsy. Nature and Science of Sleep 9, pages 39-57.
Read now
Read now
Stefano de Biase, Annacarmen Nilo, Gian Luigi Gigli & Mariarosaria Valente. (2017) Investigational therapies for the treatment of narcolepsy. Expert Opinion on Investigational Drugs 26:8, pages 953-963.
Read now
Read now
Dariusz R Wozniak & Timothy G Quinnell. (2015) Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nature and Science of Sleep 7, pages 51-61.
Read now
Read now
Articles from other publishers (40)
Éva Rumpler, Balázs Göcz, Katalin Skrapits, Miklós Sárvári, Szabolcs Takács, Imre Farkas, Szilárd Póliska, Márton Papp, Norbert Solymosi & Erik Hrabovszky. (2023) Development of a versatile LCM-Seq method for spatial transcriptomics of fluorescently-tagged cholinergic neuron populations. Journal of Biological Chemistry, pages 105121.
Crossref
Crossref
Elena Alvarez-Salas, Cinthia García-Luna & Patricia de Gortari. (2023) New Efforts to Demonstrate the Successful Use of TRH as a Therapeutic Agent. International Journal of Molecular Sciences 24:13, pages 11047.
Crossref
Crossref
Solene Masloh, Maxime Culot, Fabien Gosselet, Anne Chevrel, Leonardo Scapozza & Magali Zeisser Labouebe. (2023) Challenges and Opportunities in the Oral Delivery of Recombinant Biologics. Pharmaceutics 15:5, pages 1415.
Crossref
Crossref
Lei Wang, Nanxi Wang, Zhibin Yan, Zhifeng Huang & Caiyun Fu. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
795
815
.
Wen-Ying Liu, Raina Ladha, Hattie Liu & Richard L. Horner. (2022) Thyrotropin-releasing hormone analog as a stable upper airway-preferring respiratory stimulant with arousal properties. Journal of Applied Physiology 133:5, pages 1067-1080.
Crossref
Crossref
Radka Trubacova, Zdenka Drastichova & Jiri Novotny. (2022) Biochemical and physiological insights into TRH receptor-mediated signaling. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Marijke H. Algera, Joseph F. Cotten, Monique van Velzen, Marieke Niesters, Martijn Boon, Daniel S. Shoham, Kaye E. Dandrea, Rutger van der Schrier & Albert Dahan. (2022) Respiratory effects of thyrotropin-releasing hormone and its analogue taltirelin on opioid-induced respiratory depression. British Journal of Anaesthesia 129:1, pages e4-e6.
Crossref
Crossref
Marieke Hyke Algera, Joseph F. Cotten, Monique van Velzen, Marieke Niesters, Martijn Boon, Daniel S. Shoham, Kaye E. Dandrea, Rutger van der Schrier & Albert Dahan. (2022) Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?. Pharmacology Research & Perspectives 10:3.
Crossref
Crossref
V. P. Martinovich & K. U. Baradzina. (2022) Peptide Hormones in Medicine: A 100-Year History. Russian Journal of Bioorganic Chemistry 48:2, pages 221-232.
Crossref
Crossref
Fan Yang, Huanhuan Zhang, Xianyu Meng, Yingge Li, Yingxin Zhou, Shenglong Ling, Demeng Sun, Pei Lv, Lei Liu, Pan Shi & Changlin Tian. (2022) Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue. Cell Research 32:9, pages 858-861.
Crossref
Crossref
Katalin Prokai-Tatrai, Vien Nguyen & Laszlo Prokai. (2021) [β-Glu2]TRH Is a Functional Antagonist of Thyrotropin-Releasing Hormone (TRH) in the Rodent Brain. International Journal of Molecular Sciences 22:12, pages 6230.
Crossref
Crossref
Fabrice Duval, Marie-Claude Mokrani, Alexis Erb, Vlad Danila, Felix Gonzalez Lopera, Jack R. Foucher & Ludovic C. Jeanjean. (2021) Thyroid axis activity and dopamine function in depression. Psychoneuroendocrinology 128, pages 105219.
Crossref
Crossref
Naotake KobayashiNorihito SatoKatsuji SugitaTsuyoshi Kihara, Katsumi KoikeTamio SugawaraYukio TadaTakayoshi Yoshikawa. (2021) Synthesis and Evaluation of <i>in Vivo</i> Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4<i>S</i>,5<i>S</i>)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide. Chemical and Pharmaceutical Bulletin 69:4, pages 314-324.
Crossref
Crossref
Kaoru Kobayashi, Yoshikazu Abe, Asuka Kawai, Takao Furihata, Takuro Endo & Hiroo Takeda. (2020) Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P‐Glycoprotein Inhibitor (Itraconazole). The Journal of Clinical Pharmacology 60:10, pages 1314-1323.
Crossref
Crossref
Juan Shen, Feng Gao, Lin Zhao, Qin Hao & Yan-Ling Yang. (2020) MicroRNA-34c promotes neuronal recovery in rats with spinal cord injury through the C-X-C motif ligand 14/Janus kinase 2/signal transducer and activator of transcription-3 axis. Chinese Medical Journal 133:18, pages 2177-2185.
Crossref
Crossref
Wen-Ying Liu, Hattie Liu, Jasmin Aggarwal, Zhi-Li Huang & Richard L Horner. (2020) Differential activating effects of thyrotropin-releasing hormone and its analog taltirelin on motor output to the tongue musculature in vivo. Sleep 43:9.
Crossref
Crossref
Tomoyuki Ijiro, Atsushi Yaguchi, Ayaka Yokoyama, Yoshikazu Abe & Sumiyoshi Kiguchi. (2020) Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya. European Journal of Pharmacology 882, pages 173271.
Crossref
Crossref
Jean-Louis Charli, Adair Rodríguez-Rodríguez, Karina Hernández-Ortega, Antonieta Cote-Vélez, Rosa María Uribe, Lorraine Jaimes-Hoy & Patricia Joseph-Bravo. (2020) The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?. Frontiers in Pharmacology 11.
Crossref
Crossref
Katalin Prokai-Tatrai, Daniel L. De La Cruz, Vien Nguyen, Benjamin P. Ross, Istvan Toth & Laszlo Prokai. (2019) Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach. Pharmaceutics 11:7, pages 349.
Crossref
Crossref
Eleonore Fröhlich & Richard Wahl. (2019) The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications. Frontiers in Neuroendocrinology 52, pages 29-43.
Crossref
Crossref
Michael Wilkinson & S. Ali Imran. 2018. Clinical Neuroendocrinology. Clinical Neuroendocrinology
97
117
.
Cong Zheng, Guiqin Chen, Yang Tan, Weiqi Zeng, Qiwei Peng, Ji Wang, Chi Cheng, Xiaoman Yang, Shuke Nie, Yan Xu, Zhentao Zhang, Stella M. Papa, Keqiang Ye & Xuebing Cao. (2018) TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Fabrice Duval. (2018) Thyroid Hormone Treatment of Mood Disorders. Current Treatment Options in Psychiatry 5:4, pages 363-376.
Crossref
Crossref
Cong Zheng, Guiqin Chen, Yang Tan, Weiqi Zeng, Qiwei Peng, Ji Wang, Chi Cheng, Xiaoman Yang, Shuke Nie, Yan Xu, Zhentao Zhang, Stella M. Papa, Keqiang Ye & Xuebing Cao. (2018) TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Naotake Kobayashi, Norihito Sato, Yuko Fujimura, Tsuyoshi Kihara, Katsuji Sugita, Kouji Takahashi, Katsumi Koike, Tamio Sugawara, Yukio Tada, Hiroshi Nakai & Takayoshi Yoshikawa. (2018)
Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
N
-[(4
S
,5
S
)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-
l
-alanyl}-(2
R
)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate)
. ACS Omega 3:10, pages 13647-13666.
Crossref
Crossref
James D. Boghosian, Anita Luethy & Joseph F. Cotten. (2018) Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats. Journal of Pharmacology and Experimental Therapeutics 366:1, pages 105-112.
Crossref
Crossref
Hadi Zarif, Agnès Petit-Paitel, Catherine Heurteaux, Joëlle Chabry & Alice Guyon. (2016) TRH modulates glutamatergic synaptic inputs on CA1 neurons of the mouse hippocampus in a biphasic manner. Neuropharmacology 110, pages 69-81.
Crossref
Crossref
Chhuttan L. Meena, Avinash Thakur, Prajwal P. Nandekar, Shyam S. Sharma, Abhay T. Sangamwar & Rahul Jain. (2016) Synthesis and biology of ring-modified l-Histidine containing thyrotropin-releasing hormone (TRH) analogues. European Journal of Medicinal Chemistry 111, pages 72-83.
Crossref
Crossref
Malcolm J. Low. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
109
175
.
Chhuttan L. Meena, Avinash Thakur, Prajwal P. Nandekar, Abhay T. Sangamwar, Shyam S. Sharma & Rahul Jain. (2015) Synthesis of CNS active thyrotropin-releasing hormone (TRH)-like peptides: Biological evaluation and effect on cognitive impairment induced by cerebral ischemia in mice. Bioorganic & Medicinal Chemistry 23:17, pages 5641-5653.
Crossref
Crossref
Tomoyuki Ijiro, Kayo Nakamura, Masanori Ogata, Hiroyuki Inada, Sumiyoshi Kiguchi, Kazuyasu Maruyama, Junichi Nabekura, Mamoru Kobayashi & Hitoshi Ishibashi. (2015) Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system. European Journal of Pharmacology 761, pages 413-422.
Crossref
Crossref
Giovanna Morello & Sebastiano Cavallaro. (2015) Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy. Future Medicinal Chemistry 7:10, pages 1335-1359.
Crossref
Crossref
Chhuttan L. Meena, Shubdha Ingole, Satyendra Rajpoot, Avinash Thakur, Prajwal P. Nandekar, Abhay T. Sangamwar, Shyam S. Sharma & Rahul Jain. (2015) Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice. RSC Advances 5:70, pages 56872-56884.
Crossref
Crossref
Ralf Paus, Ewan A. Langan, Silvia Vidali, Yuval Ramot & Bogi Andersen. (2014) Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends in Molecular Medicine 20:10, pages 559-570.
Crossref
Crossref
Elke Clynen, Ann Swijsen, Marjolein Raijmakers, Govert Hoogland & Jean-Michel Rigo. (2014) Neuropeptides as Targets for the Development of Anticonvulsant Drugs. Molecular Neurobiology 50:2, pages 626-646.
Crossref
Crossref
Pravin Bagul, Kailas S. Khomane, Siddharth S. Kesharwani, Preeti Pragyan, Prajwal P. Nandekar, Chhuttan Lal Meena, Arvind K. Bansal, Rahul Jain, Kulbhushan Tikoo & Abhay T. Sangamwar. (2014)
Intestinal transport of TRH analogs through PepT1: the role of
in silico
and
in vitro
modeling
. Journal of Molecular Recognition 27:10, pages 609-617.
Crossref
Crossref
Yuval Ramot & Ralf Paus. (2014) Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?. BioEssays 36:7, pages 672-686.
Crossref
Crossref
Y. Ramot, G. Zhang, T. Bíró, L. Langbein & R. Paus. (2013) Is thyrotropin-releasing hormone a novel neuroendocrine modulator of keratin expression in human skin?. British Journal of Dermatology 169:1, pages 146-151.
Crossref
Crossref
Katalin Prokai-Tatrai, Vien Nguyen, Szabolcs Szarka, Krisztina Konya & Laszlo Prokai. (2013) Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs. Pharmaceutics 5:4, pages 318-328.
Crossref
Crossref
Nanthakumar Thirunarayanan, Eshel A Nir, Bruce M Raaka & Marvin C Gershengorn. (2012) Thyrotropin-Releasing Hormone Receptor Type 1 (TRH-R1), not TRH-R2, Primarily Mediates Taltirelin Actions in the CNS of Mice. Neuropsychopharmacology 38:6, pages 950-956.
Crossref
Crossref